2020
DOI: 10.1002/rth2.12283
|View full text |Cite
|
Sign up to set email alerts
|

Not all (N)SAID and done: Effects of nonsteroidal anti‐inflammatory drugs and paracetamol intake on platelets

Abstract: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. AbstractPlatelets are key mediators of hemostasis and thrombosis and can be inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs). As a result, platelet donors are temporarily deferred from donating if they have recently taken … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 97 publications
0
11
0
Order By: Relevance
“…However, another intriguing possibility is that the effectiveness of paracetamol is actually less affected by platelet count in comparison with indomethacin and ibuprofen. In fact, both of these drugs are known to inhibit thromboxane release and impair platelet aggregation (enhancing the effect of thrombocytopenia in favoring the development of hsPDA), while paracetamol has been reported to have a negligible effect on platelet aggregation, making its closing effect on hsPDA less easily influenced by thrombocytopenia [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, another intriguing possibility is that the effectiveness of paracetamol is actually less affected by platelet count in comparison with indomethacin and ibuprofen. In fact, both of these drugs are known to inhibit thromboxane release and impair platelet aggregation (enhancing the effect of thrombocytopenia in favoring the development of hsPDA), while paracetamol has been reported to have a negligible effect on platelet aggregation, making its closing effect on hsPDA less easily influenced by thrombocytopenia [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…It is important to note that smoking has been found to increase clotting activity in PRP and to delay tendon-to-bone healing after rotator cuff repair surgery. 13 , 40 Diabetes has also been shown to affect healing rates following arthroscopic rotator cuff repair, 8 and antiplatelet/anti-inflammatory medications should be addressed because such medications inhibit platelet aggregation. 11 The influence of comorbidity factors on platelet function and PRP characteristics emphasizes the importance of recording comorbidities to evaluate the effectiveness of PRP as an adjunct in full-thickness rotator cuff tear repair.…”
Section: Discussionmentioning
confidence: 99%
“…Aspirin irreversibly acetylates COX-1 and prevents arachidonic acid from entering the active site, thereby reducing the production of thromboxane A2 and resulting in thrombocytopenia. 90 Aspirin promotes the production of resorcinol, an anti-inflammatory and pro-decomposition lipid medium. Aspirin also acetylated the COX-2-activated pathway for enzymatic production and combined with choline had good effects on foot swelling induced by carrageenan in mice and inflammatory pain induced by LPS in mice.…”
Section: Mechanism Of Drugs Intervention On Chronic Inflammatory Pain...mentioning
confidence: 99%